{"id":396755,"date":"2025-04-19T01:05:00","date_gmt":"2025-04-18T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/no-more-transplants-for-relapsed-or-refractory-hl-in-the-future\/"},"modified":"2025-04-18T23:58:26","modified_gmt":"2025-04-18T21:58:26","slug":"no-more-transplants-for-relapsed-or-refractory-hl-in-the-future","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/no-more-transplants-for-relapsed-or-refractory-hl-in-the-future\/","title":{"rendered":"No more transplants for relapsed or refractory HL in the future?"},"content":{"rendered":"\n

The standard treatment approach for relapsed or refractory (RR) classical Hodgkin’s lymphoma (HL) after failure of first-line treatment is second-line therapy with the aim of achieving complete remission (CR), followed by consolidation with high-dose therapy and autologous hematopoietic cell transplantation (HDT\/AHCT). Researchers investigated whether transplantation can be dispensed with in the future under certain conditions. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

The standard treatment approach for relapsed or refractory (RR) classical Hodgkin’s lymphoma (HL) after failure of first-line treatment is second-line therapy with the aim of achieving complete remission (CR), followed……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396756,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Hodgkin's lymphoma ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11353,11370,11503],"tags":[81756,81779,9476,25741,81830,12952,5622,3614],"powerkit_post_featured":[],"class_list":["post-396755","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-hematology","category-oncology","category-studies","tag-ash-2024","tag-ash-2024-en","tag-hl","tag-hl-en","tag-hodgkins-lymphoma-en-2","tag-hodgkins-lymphoma","tag-pembrolizumab","tag-transplantation","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-17 06:06:06","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":396749,"slug":"plus-de-transplantation-a-lavenir-pour-le-lh-recidivant-ou-refractaire","post_title":"Plus de transplantation \u00e0 l'avenir pour le LH r\u00e9cidivant ou r\u00e9fractaire ?","href":"https:\/\/medizinonline.com\/fr\/plus-de-transplantation-a-lavenir-pour-le-lh-recidivant-ou-refractaire\/"},"it_IT":{"locale":"it_IT","id":396743,"slug":"non-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro","post_title":"Non ci saranno pi\u00f9 trapianti per la HL recidivata o refrattaria in futuro?","href":"https:\/\/medizinonline.com\/it\/non-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro\/"},"pt_PT":{"locale":"pt_PT","id":396739,"slug":"nao-havera-mais-transplantes-para-o-lh-recidivante-ou-refratario-no-futuro","post_title":"N\u00e3o haver\u00e1 mais transplantes para o LH recidivante ou refrat\u00e1rio no futuro?","href":"https:\/\/medizinonline.com\/pt-pt\/nao-havera-mais-transplantes-para-o-lh-recidivante-ou-refratario-no-futuro\/"},"es_ES":{"locale":"es_ES","id":396733,"slug":"no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro","post_title":"\u00bfNo habr\u00e1 m\u00e1s trasplantes para el LH recidivante o refractario en el futuro?","href":"https:\/\/medizinonline.com\/es\/no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=396755"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396755\/revisions"}],"predecessor-version":[{"id":398457,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/396755\/revisions\/398457"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/396756"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=396755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=396755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=396755"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=396755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}